DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/84xggm/global_alzheimer) has announced the addition of the "Global Alzheimer Market Report: 2015 Edition" report to their offering.
The report, Global Alzheimer Market analyzes the currently prevailing condition of the market along with its future scope of development. The global market along with specific markets of the U.S., Europe (including the UK) and Asia-Pacific are being discussed in the report. The major trends, growth drivers as well as issues being faced by the industry are being presented in this report. The major players in the industry are being profiled, along with their key financials and strategies for growth.
The current market for Alzheimer's disease drugs is limited as only few drugs have been approved thus, defining a healthy scope of introduction of new drugs in the market in the coming years. The healthcare costs associated with Alzheimer's are also anticipated to rise considerably since only limited treatment options are available in the market. The Alzheimer market expects introduction of innovative small molecules, biopharmaceuticals and disease modifying agents that would help transform the pattern of Alzheimer's disease.
Increasing ageing population, growing population of women, rising life expectancy, increasing healthcare expenditure, improving economic conditions, and increasing global spending on medicines are some of the major factors contributing to the growth of Alzheimer's disease market. However, the growth of the market is hindered by certain challenges including lack of availability of effective treatment options, problems in detection and diagnosis, and insufficient research funding.
- Growing Ageing Population
- Increasing Population of Women
- Rising Life Expectancy
- Rising Healthcare Expenditure
- Improving Economic Conditions
- Increasing Global Spending on Medicines
Key Trends and Developments
- Pipeline Drugs under Development
- Alzheimer as a Major Cause of Deaths in the U.S.
- Development of 5-HT6 Antagonists
- Higher Lifetime Risk for Women
- Lack of Effective Treatment Options
- Insufficient Research Funding
- Difficulty in Detection and Diagnosis
Key Topics Covered:
2. Market Analysis
3. Regional Markets
4. Market Dynamics
5. Competitive Landscape
6. Company Profiles
- Forest Laboratories, Inc.
- Johnson & Johnson
- Pfizer, Inc.
- Roche Holdings
For more information visit http://www.researchandmarkets.com/research/84xggm/global_alzheimer